Atlas Trials

The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

Clinical trial NCT07069842 · RECRUITING

Trial details

NCT number
NCT07069842
Sponsor
Changzhi People's Hospital Affiliated to Changzhi Medical College
Status
RECRUITING
Study type
OBSERVATIONAL
Gastric CancerImmunotherapy
Start date
2025-01-01
Primary completion
2026-01-01
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.